Role of microRNA-34 family in cancer with particular reference to cancer angiogenesis. (Q38237787)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25102298%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

title

Role of microRNA-34 family in cancer with particular reference to cancer angiogenesis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25102298%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25102298%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Alfred King-Yin Lam

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25102298%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

author name string

Hamidreza Maroof

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25102298%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Robert Anthony Smith

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25102298%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

publication date

4 August 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25102298%20AND%20SRC:MED&resulttype=core&format=json

Experimental and Molecular Pathology

12 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25102298%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

volume

97

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25102298%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25102298%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

page(s)

298-304

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25102298%20AND%20SRC:MED&resulttype=core&format=json

Independent radiologic review: bevacizumab in combination with gemcitabine and carboplatin in recurrent ovarian cancer

12 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Up-regulation of miR-210 by vascular endothelial growth factor in ex vivo expanded CD34+ cells enhances cell-mediated angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

MicroRNAs and developmental timing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1α

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Bevacizumab-induced normalization of blood vessels in tumors hampers antibody uptake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

The promise of microRNA replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Use of anti-VEGF adjuvant therapy in cancer: challenges and rationale

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Let-7 in cardiovascular diseases, heart development and cardiovascular differentiation from stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

A mammalian microRNA cluster controls DNA methylation and telomere recombination via Rbl2-dependent regulation of DNA methyltransferases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

p53-mediated activation of miRNA34 candidate tumor-suppressor genes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Angiogenesis in embryonic development--a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

How does SIRT1 affect metabolism, senescence and cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

A brief review on the mechanisms of miRNA regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Angiogenesis in life, disease and medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

MicroRNA in prostate, bladder, and kidney cancer: a systematic review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

MiRNA-34 intrinsically links p53 tumor suppressor and Wnt signaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Effect of microRNA-34a in cell cycle, differentiation, and apoptosis: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Tumor-associated macrophages: the double-edged sword in cancer progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

MicroRNA-378 is associated with non-small cell lung cancer brain metastasis by promoting cell migration, invasion and tumor angiogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Epigenetic inactivation of the miR-34a in hematological malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Overexpression of Dicer in precursor lesions of lung adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

miR-34 miRNAs provide a barrier for somatic cell reprogramming

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Intact p53-dependent responses in miR-34-deficient mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Frequent downregulation of miR-34 family in human ovarian cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

MiR-34a targeting of Notch ligand delta-like 1 impairs CD15+/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Members of the microRNA-17-92 cluster exhibit a cell-intrinsic antiangiogenic function in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

miR-126 in human cancers: clinical roles and current perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

VEGF and the quest for tumour angiogenesis factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Angiogenesis as a therapeutic target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

The biology of VEGF and its receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Molecular mechanisms of vasculogenesis and embryonic angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

MicroRNAs in skeletal myogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-α isoforms and promotes angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

The miR-34 family in cancer and apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Embryonic stem cell-specific MicroRNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Cationic microRNA-delivering nanovectors with bifunctional peptides for efficient treatment of PANC-1 xenograft model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Biological functions of microRNAs: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

MicroRNA control of signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Expression profile of endothelin 1 and its receptor endothelin receptor A in papillary thyroid carcinoma and their correlations with clinicopathologic characteristics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

A review of the profile of endothelin axis in cancer and its management.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

MicroRNA-34a regulation of endothelial senescence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Downregulation of miR-34a in breast tumors is not associated with either p53 mutations or promoter hypermethylation while it correlates with metastasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Reduced expression of Dicer associated with poor prognosis in lung cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

The mir-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Interleukin-8 as a macrophage-derived mediator of angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Hepatic microRNA profiles offer predictive and mechanistic insights after exposure to genotoxic and epigenetic hepatocarcinogens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

The widespread regulation of microRNA biogenesis, function and decay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Epigenetic silencing of microRNA-34b/c plays an important role in the pathogenesis of malignant pleural mesothelioma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Suppression of non-small cell lung tumor development by the let-7 microRNA family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Dysregulation of microRNA-34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Identification of tissue-specific microRNAs from mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Capture of microRNA-bound mRNAs identifies the tumor suppressor miR-34a as a regulator of growth factor signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

An extensive class of small RNAs in Caenorhabditis elegans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Timing specific requirement of microRNA function is essential for embryonic and postnatal hippocampal development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1α expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

The microRNA miR-34 modulates ageing and neurodegeneration in Drosophila

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Angiopoietin and Tie signaling pathways in vascular development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Antiangiogenesis enhances intratumoral drug retention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Advances in the structural biology, design and clinical development of VEGF-R kinase inhibitors for the treatment of angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Epigenetic regulation of microRNA genes and the role of miR-34b in cell invasion and motility in human melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Tumour angiogenesis and its relation to contrast enhancement on computed tomography: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Global microRNA profiles in cervical squamous cell carcinoma depend on Drosha expression levels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Down-regulation of mir-424 contributes to the abnormal angiogenesis via MEK1 and cyclin E1 in senile hemangioma: its implications to therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

miR-221 is required for endothelial tip cell behaviors during vascular development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Understanding the biology of angiogenesis: review of the most important molecular mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

A phase 3 trial of bevacizumab in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

miR-200c regulates FGFR-dependent epithelial proliferation via Vldlr during submandibular gland branching morphogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Increased expression of MMP-9 and IL-8 are correlated with poor prognosis of Bladder Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Concomitant MYC and microRNA cluster miR-17-92 (C13orf25) amplification in human mantle cell lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Single nucleotide polymorphisms and mRNA expression of VEGF-A in papillary thyroid carcinoma: potential markers for aggressive phenotypes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Co-regulatory potential of vascular endothelial growth factor-A and vascular endothelial growth factor-C in thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

miR-296/Scribble axis is deregulated in human breast cancer and miR-296 restoration reduces tumour growth in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

MicroRNAs in development and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Hypoxia, clonal selection, and the role of HIF-1 in tumor progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

HIF-1 and tumor progression: pathophysiology and therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

MicroRNA genes are frequently located near mouse cancer susceptibility loci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Anti-angiogenesis therapy in cancer: current challenges and future perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Detection of miR-34a promoter methylation in combination with elevated expression of c-Met and β-catenin predicts distant metastasis of colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Posttranscriptional regulation of microRNA biogenesis in animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Anti-VEGF/VEGFR therapy for cancer: reassessing the target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Cross talk between microRNA and epigenetic regulation in adult neurogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Erlotinib in lung cancer - molecular and clinical predictors of outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

miR-296 regulation of a cell polarity-cell plasticity module controls tumor progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

MicroRNA regulation by RNA-binding proteins and its implications for cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

miRNA response to DNA damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Cardiomyocytes mediate anti-angiogenesis in type 2 diabetic rats through the exosomal transfer of miR-320 into endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

MicroRNAs associated with metastatic prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

The interleukin-8 pathway in cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Irinotecan and colorectal cancer: the role of p53, VEGF-C and alpha-B-crystallin expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Many roads to maturity: microRNA biogenesis pathways and their regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

miR-320 regulates tumor angiogenesis driven by vascular endothelial cells in oral cancer by silencing neuropilin 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

MiR-34, SIRT1 and p53: the feedback loop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

miR-34a repression of SIRT1 regulates apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Dicer is required for embryonic angiogenesis during mouse development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

The potential clinical relevance of serum vascular endothelial growth factor (VEGF) and VEGF-C in recurrent papillary thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

MicroRNA 34c gene down-regulation via DNA methylation promotes self-renewal and epithelial-mesenchymal transition in breast tumor-initiating cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Dysregulation of angiogenesis-related microRNAs in endothelial progenitor cells from patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

MicroRNA-217 promotes angiogenesis of human cytomegalovirus-infected endothelial cells through downregulation of SIRT1 and FOXO3A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002

Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.08.002